Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-022812
Filing Date
2025-08-08
Accepted
2025-08-08 17:10:29
Documents
20
Period of Report
2025-08-08

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 529843
2 GRAPHIC proxy_001.jpg GRAPHIC 456685
3 GRAPHIC proxy_002.jpg GRAPHIC 247808
4 GRAPHIC proxy_003.jpg GRAPHIC 272281
5 GRAPHIC proxy_004.jpg GRAPHIC 384470
  Complete submission text file 0001641172-25-022812.txt   4630914

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE brtx-20241231.xsd EX-101.SCH 5906
7 XBRL DEFINITION FILE brtx-20241231_def.xml EX-101.DEF 10067
8 XBRL LABEL FILE brtx-20241231_lab.xml EX-101.LAB 63598
9 XBRL PRESENTATION FILE brtx-20241231_pre.xml EX-101.PRE 42733
22 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 113116
Mailing Address 40 MARCUS DRIVE MELVILLE NY 11747
Business Address 40 MARCUS DRIVE MELVILLE NY 11747 (631) 760-8100
BioRestorative Therapies, Inc. (Filer) CIK: 0001505497 (see all company filings)

EIN.: 301341024 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37603 | Film No.: 251199366
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 08 Industrial Applications and Services)